Header cover image

Israeli (TA) Biotech Industry Analysis

UpdatedJun 30, 2022
DataAggregated Company Financials
  • 7D-0.6%
  • 3M-24.7%
  • 1Y-54.8%
  • YTD-45.3%

Over the last 7 days, the Biotech industry has remained flat, although notably Can-Fite BioPharma gained 14%. As for the longer term, the industry has declined 55% in the last year. Looking forward, earnings are forecast to grow by 55% annually.

Industry Valuation and Performance

Has the Israeli Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Fri, 01 Jul 2022₪2.1b₪494.4m-₪401,552,695.0012.6x
Sun, 29 May 2022₪2.2b₪482.7m-₪435,253,162.0013.8x
Tue, 26 Apr 2022₪2.8b₪466.4m-₪499,790,987.0014x
Thu, 24 Mar 2022₪2.8b₪459.0m-₪216,239,616.003.4x
Sat, 19 Feb 2022₪2.9b₪457.8m-₪220,956,082.007.1x
Mon, 17 Jan 2022₪3.6b₪447.6m-₪213,865,355.006.7x
Wed, 15 Dec 2021₪3.5b₪436.9m-₪213,453,475.009x
Fri, 12 Nov 2021₪3.9b₪462.7m-₪167,516,669.0010x
Sun, 10 Oct 2021₪4.1b₪476.0m-₪174,362,856.0010.3x
Tue, 07 Sep 2021₪4.4b₪479.4m-₪177,420,697.107.2x
Thu, 05 Aug 2021₪4.0b₪483.2m-₪167,305,098.004.7x
Sun, 09 May 2021₪4.2b₪528.7m-₪109,530,611.003.6x
Wed, 10 Feb 2021₪4.3b₪520.8m-₪60,037,930.402.8x
Tue, 03 Nov 2020₪2.7b₪546.7m-₪199,116,926.709.9x
Fri, 07 Aug 2020₪2.4b₪541.9m-₪227,418,479.0010.9x
Thu, 30 Apr 2020₪2.2b₪616.6m-₪322,626,634.70121x
Sun, 02 Feb 2020₪1.6b₪563.9m-₪314,626,521.2017.3x
Wed, 06 Nov 2019₪1.5b₪609.2m-₪219,539,279.0017.5x
Sat, 10 Aug 2019₪1.7b₪548.7m-₪236,195,260.9026.6x
Median PE Ratio


Total Market Cap: ₪1.8bTotal Earnings: -₪236,195,260.90Total Revenue: ₪548.7mTotal Market Cap vs Earnings and Revenue0%0%0%
Israeli Biotech Industry Median PE3Y Average 19.7x202020212022
Current Industry PE
  • Investors are pessimistic on the industry, indicating that they anticipate long-term growth rates will be lower than they have historically.
  • The industry's 3-year average PS ratio 5.5x is higher than the industry's current PS ratio of 4.3x.
Past Earnings Growth
  • The earnings for companies in the Biotechnology industry have deteriorated over the last three years.
  • Revenues have also declined 3.4% per year.
  • This means overall sales from these companies are declining and losses are subsequently expanding as well.

Industry Comparison

How does Israeli Biotech compare with similar industries?

IL Market1.61%
Industry PEThere is insufficient data on the sub-industries of this industry.
Forecasted GrowthThere is insufficient data on the sub-industries of this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
KMDA Kamada₪15.893.7%
CANF Can-Fite BioPharma₪0.116.0%
NXTG Nextage Therapeutics₪1.228.4%
XTLB XTL Biopharmaceuticals₪0.0543.8%
Simply Wall St
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News